Stay updated on Nivolumab for Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Hematologic Malignancies Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Locations section now includes Victoria (Parkville, Victoria) as a trial site. The HHS Vulnerability Disclosure footer link was removed and the revision note updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:12:07.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The page revision history shows the addition of Revision v3.3.2 and the removal of Revision v3.2.0; these are non-substantive updates that do not affect the study details or data presented.
    Difference
    0.1%
    Check dated 2025-11-25T10:56:41.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page; core study information such as the title, eligibility criteria, locations, and contacts remains visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:45.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Cosmetic updates to the page layout and styling are visible in the new screenshot, while core study data such as eligibility criteria and outcomes remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T21:04:19.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Added a government-status notice and external links, clarifying operating status and processing behavior. - Updated revision version from v3.1.0 to v3.2.0.
    Difference
    6%
    Check dated 2025-10-06T05:35:42.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:06:25.000Z thumbnail image

Stay in the know with updates to Nivolumab for Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Hematologic Malignancies Clinical Trial page.